Matthew Smeltzer

Associate Professor

University of Memphis

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Matthew Smeltzer is an Associate Professor at the University of Memphis, United States. His research focuses on lung cancer biomarker testing, the management of sickle cell disease, and the impact of mRNA vaccination against SARS-CoV-2. His recent publications include studies on the effectiveness of multidisciplinary lung cancer care and the challenges in the care of sickle cell patients transitioning to adulthood.

Articles (15)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (16)

Julie Kanter

UNITED STATES

Matthew Smeltzer

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

The 2024 International Association for the Study of Lung Cancer Global Survey on Biomarker Testing

Prevalence of Epidermal Growth Factor Receptor and Programmed Death Ligand 1 Testing in a Population-Based Lung Cancer Surgical Resection Cohort from 2018 to 2022

Gaps during pediatric to adult care transfer escalate acute resource utilization in sickle cell disease

Hydroxyurea at escalated dose versus fixed low‐dose hydroxyurea in adults with sickle cell disease

Urinary angiotensinogen is associated with albuminuria in adults with sickle cell anaemia.

Common data model for sickle cell disease surveillance: considerations and implications

Provider prescription of hydroxyurea in youth and adults with sickle cell disease: A review of prescription barriers and facilitators

Prospective Comparative Effectiveness Trial of Multidisciplinary Lung Cancer Care Within a Community-Based Health Care System

Association Between mRNA Vaccination and Infection From SARS-CoV-2 During the Delta and Omicron BA.1 Waves: A Population-Level Analysis

Real-World Association Between mRNA Vaccination and Infection From the Omicron Strain of SARS-CoV-2: A Population-Level Analysis

Statistical considerations for outcomes in clinical research: A review of common data types and methodology

Identifying barriers to evidence-based care for sickle cell disease

Developmental screening of three‐year‐old children with sickle cell disease compared to controls

Hydroxyurea therapy decreases coagulation and endothelial activation in sickle cell disease: a Longitudinal Study

Equity-Driven Approaches to Optimizing Cancer Care Coordination and Reducing Care Delivery Disparities in Underserved Patient Populations in the United States

Collaborators (16)

Julie Kanter

Sherif M. Badawy

Jennifer King

Mariam Kayle

Robert W. Gibson

Lin Wu

Molly Beestrum

Kristen Howell

Kevin Dombkowski

Angela Snyder

Praghalathan Kanthakumar

Ugochi Ogu

Nirmish Shah

Nicole M. Alberts

Kenneth I. Ataga

Adebowale Adebiyi

Make your next move.